Next generation therapeutics for Alzheimer's disease
Abstract To date, no truly effective therapy has been developed for Alzheimer's disease or mild cognitive impairment. In searching for new approaches that may succeed where previous ones have failed, it may be instructive to consider the successful therapeutic developments for other chronic ill...
Auteurs principaux: | Dale E. Bredesen, Varghese John |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Springer Nature
2013-05-01
|
Collection: | EMBO Molecular Medicine |
Sujets: | |
Accès en ligne: | https://doi.org/10.1002/emmm.201202307 |
Documents similaires
Documents similaires
-
Potential Antioxidant Multitherapy against Complications Occurring in Sepsis
par: Joaquin Abelli, et autres
Publié: (2022-12-01) -
Emerging advances in fluorescence imaging and phototherapy of arthritis
par: Xiaoxuan Wang, et autres
Publié: (2023-11-01) -
Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives
par: María Gabriela Montiel Schneider, et autres
Publié: (2022-01-01) -
Editorial: Highlights in Alzheimer's and Parkinson's disease
par: Mariagiovanna Cantone, et autres
Publié: (2023-08-01) -
Insights from Turkey's big data: unraveling the preventability, pathogenesis, and risk management of Alzheimer's disease (AD)
par: Talip Yiğit, et autres
Publié: (2024-03-01)